Geron abandons stem cell therapy as treatment for paralysis

Professor John Martin (UCL Cardiovascular Medicine) comments on the announcement by biotech company Geron that it will abandon the first ever stem cell trial to treat paralysis. Read: Guardian More: FT New Scientist BBC News Online